Core Viewpoint - The company, Aoke Co., Ltd. (300082.SZ), has achieved EXCiPACT certification for its pharmaceutical-grade polyethylene glycol products and is currently serving over 400 pharmaceutical formulation enterprises, although its products do not yet cover the brain-machine interface field [1] Group 1 - The company has successfully obtained EXCiPACT certification for its entire range of pharmaceutical-grade polyethylene glycol [1] - The company is currently providing services to more than 400 pharmaceutical formulation enterprises [1] - The company indicates that if there are any developments in business expansion that meet disclosure standards, it will announce them in accordance with legal and regulatory requirements [1] Group 2 - The company emphasizes its commitment to continuous innovation and stable production capacity to serve its clients [1] - The company aims to promote the development of high-end application fields [1]

Core Viewpoint - The company has achieved EXCiPACT certification for its pharmaceutical-grade polyethylene glycol products and is currently serving over 400 pharmaceutical formulation enterprises, although its products do not yet extend to the brain-machine interface field [1] Group 1: Company Developments - The company has successfully passed EXCiPACT certification for its entire range of pharmaceutical-grade polyethylene glycol [1] - The company is currently providing services to more than 400 pharmaceutical formulation enterprises [1] - The company will disclose specific business expansion details in accordance with legal and regulatory standards if they meet the disclosure criteria [1] Group 2: Future Outlook - The company aims to continue leveraging innovative technologies and stable production capacity to serve its clients [1] - The company is focused on promoting the development of high-end application areas [1]

Core Viewpoint - The company, Aoke Co., Ltd. (300082), clarified that its pharmaceutical-grade polyethylene glycol products are primarily used as pharmaceutical excipients and raw materials, and do not directly participate in innovative drug development [1] Company Summary - Aoke Co., Ltd. has confirmed that its products serve as pharmaceutical excipients and raw materials [1] - The company has disclosed relevant information regarding its operations in regular reports [1]